Citigroup’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $53.9M | Sell |
1,248,505
-153,008
| -11% | -$6.61M | 0.03% | 423 |
|
|
2025
Q1 | $48.5M | Sell |
1,401,513
-137,219
| -9% | -$4.74M | 0.02% | 415 |
|
|
2024
Q4 | $42.2M | Buy |
1,538,732
+929
| +0.1% | +$25.5K | 0.03% | 403 |
|
|
2024
Q3 | $39.2M | Buy |
1,537,803
+222,464
| +17% | +$5.66M | 0.02% | 444 |
|
|
2024
Q2 | $33.3M | Sell |
1,315,339
-474,731
| -27% | -$12M | 0.02% | 480 |
|
|
2024
Q1 | $55.3M | Buy |
1,790,070
+232,839
| +15% | +$7.2M | 0.04% | 308 |
|
|
2023
Q4 | $62.9M | Sell |
1,557,231
-30,361
| -2% | -$1.23M | 0.04% | 250 |
|
|
2023
Q3 | $41.9M | Buy |
1,587,592
+160,076
| +11% | +$4.22M | 0.03% | 334 |
|
|
2023
Q2 | $24.6M | Sell |
1,427,516
-119,529
| -8% | -$2.06M | 0.02% | 516 |
|
|
2023
Q1 | $25.7M | Buy |
1,547,045
+162,116
| +12% | +$2.69M | 0.02% | 515 |
|
|
2022
Q4 | $10.6M | Sell |
1,384,929
-135,132
| -9% | -$1.03M | 0.01% | 790 |
|
|
2022
Q3 | $15.1M | Buy |
1,520,061
+45,659
| +3% | +$454K | 0.01% | 665 |
|
|
2022
Q2 | $13.4M | Buy |
1,474,402
+343,362
| +30% | +$3.12M | 0.01% | 723 |
|
|
2022
Q1 | $11.5M | Sell |
1,131,040
-81,298
| -7% | -$825K | 0.01% | 861 |
|
|
2021
Q4 | $20.2M | Buy |
1,212,338
+735,295
| +154% | +$12.3M | 0.01% | 663 |
|
|
2021
Q3 | $22.4M | Sell |
477,043
-152,317
| -24% | -$7.14M | 0.01% | 647 |
|
|
2021
Q2 | $38.4M | Buy |
629,360
+25,960
| +4% | +$1.58M | 0.02% | 471 |
|
|
2021
Q1 | $37.2M | Buy |
603,400
+63,047
| +12% | +$3.88M | 0.02% | 472 |
|
|
2020
Q4 | $38.4M | Sell |
540,353
-186,055
| -26% | -$13.2M | 0.02% | 426 |
|
|
2020
Q3 | $27.3M | Sell |
726,408
-84,405
| -10% | -$3.17M | 0.02% | 478 |
|
|
2020
Q2 | $26.4M | Buy |
810,813
+693,775
| +593% | +$22.6M | 0.02% | 410 |
|
|
2020
Q1 | $3.39M | Buy |
117,038
+92,075
| +369% | +$2.67M | ﹤0.01% | 1126 |
|
|
2019
Q4 | $874K | Buy |
24,963
+23,959
| +2,386% | +$839K | ﹤0.01% | 2288 |
|
|
2019
Q3 | $21K | Buy |
+1,004
| New | +$21K | ﹤0.01% | 4244 |
|